These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
736 related articles for article (PubMed ID: 11063653)
41. Lymphatic spread among women with primary peritoneal carcinoma. Eltabbakh GH; Mount SL J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724 [TBL] [Abstract][Full Text] [Related]
42. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. Morice P; Joulie F; Camatte S; Atallah D; Rouzier R; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D J Am Coll Surg; 2003 Aug; 197(2):198-205. PubMed ID: 12892797 [TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer. Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383 [TBL] [Abstract][Full Text] [Related]
44. [Lymphadenectomy in the treatment of malignant ovarian germ cell tumor]. Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):743-8. PubMed ID: 16447650 [TBL] [Abstract][Full Text] [Related]
45. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261 [TBL] [Abstract][Full Text] [Related]
46. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Aletti GD; Dowdy S; Podratz KC; Cliby WA Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488 [TBL] [Abstract][Full Text] [Related]
47. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? Bollschweiler E; Baldus SE; Schröder W; Schneider PM; Hölscher AH J Surg Oncol; 2006 Oct; 94(5):355-63. PubMed ID: 16967455 [TBL] [Abstract][Full Text] [Related]
48. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma. Djordjevic B; Malpica A Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998 [TBL] [Abstract][Full Text] [Related]
49. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [TBL] [Abstract][Full Text] [Related]
50. Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome. Iguchi C; Nio Y; Itakura M J Surg Oncol; 2003 Jun; 83(2):85-93. PubMed ID: 12772201 [TBL] [Abstract][Full Text] [Related]
51. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S; J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344 [TBL] [Abstract][Full Text] [Related]
52. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer. Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217 [TBL] [Abstract][Full Text] [Related]
53. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP; J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437 [TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Lee HY; Choi HJ; Park KJ; Shin JS; Kwon HC; Roh MS; Kim C Ann Surg Oncol; 2007 May; 14(5):1712-7. PubMed ID: 17253102 [TBL] [Abstract][Full Text] [Related]
55. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis. Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424 [TBL] [Abstract][Full Text] [Related]
56. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma]. Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460 [TBL] [Abstract][Full Text] [Related]
57. Endometrial cancer in premenopausal women 45 years and younger. Gitsch G; Hanzal E; Jensen D; Hacker NF Obstet Gynecol; 1995 Apr; 85(4):504-8. PubMed ID: 7898824 [TBL] [Abstract][Full Text] [Related]
58. Analysis of FIGO Stage IIIc endometrial cancer patients. McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962 [TBL] [Abstract][Full Text] [Related]
59. [Risk factors and prognosis of node-positive cervical carcinoma]. Feng SY; Zhang YN; Liu JG Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145 [TBL] [Abstract][Full Text] [Related]
60. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]